National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

EPOCH regimen
A chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin) and doxorubicin hydrochloride (hydroxydaunorubicin hycrochloride), which may be used in combination with rituximab (R-EPOCH) for the treatment of various aggressive B cell and T cell non-Hodgkin lymphomas. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Etoposide-Prednisone-Oncovin-Cyclophosphamide-Hydroxydaunorubicin regimen
Acronym:CHEOP regimen



Previous:EP-2101, EpiCept NP-1, epirubicin hydrochloride, Epitol, Epivir
Next:epoetin alfa, epoetin beta, Epogen, epothilone B, epothilone D

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov